Publication Name	World Journal of Gastroenterology
Manuscript ID	7193
Country	China

Received	2013-11-08 20:00
Peer-Review Started	2013-11-10 20:46
To Make the First Decision	2013-12-04 09:13
Return for Revision	2013-12-16 12:14
Revised
Second Decision	2014-03-19 13:43
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2014-03-19 15:23
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2014-05-14 18:37
Publish the Manuscript Online	2014-05-28 11:45

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Topic Highlights
Article Title	Impact of antiviral therapy on post-hepatectomy outcome for hepatitis B-related hepatocellular carcinoma
Manuscript Source	Invited Manuscript
All Author List	Charing Ching Ning Chong, Grace Lai Hung Wong and Paul Bo San Lai
Funding Agency and Grant Number
Corresponding Author	Charing Ching Ning Chong, MBChB, MSc, FCSHK, Division of Hepato-biliary and Pancreatic Surgery, Department of Surgery, Prince of Wales Hospital, the Chinese University of Hong Kong, 30-32 Ngan Shing Street, Shatin, Hong Kong, China. chongcn@surgery.cuhk.edu.hk
Key Words	Antiviral therapy; Hepatitis B infection; Hepatocellular carcinoma; Hepatectomy; Liver resection; Outcome
Core Tip	The impact of antiviral therapy on clinical outcomes after curative liver resection in patients with hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) remains to be established. There are increasing evidence to suggest that antiviral therapy could suppress HBV replication, decrease the perioperative reactivation of virus, reduce liver injury, preserve the liver function before and after operation, and may lower the risk of HCC recurrence. Antiviral therapy may also improve the survival after liver resection by reducing recurrence and delaying the liver damage by the virus, rendering in a higher chance of receiving aggressive salvage therapy during HCC recurrence. We herein review the currently available evidences on this issue.
Publish Date	2014-05-28 11:45
Citation	Chong CCN, Wong GLH, Lai PBS. Impact of antiviral therapy on post-hepatectomy outcome for hepatitis B-related hepatocellular carcinoma. World J Gastroenterol 2014; 20(20): 6006-6012
URL	http://www.wjgnet.com/1007-9327/full/v20/i20/6006.htm
DOI	http://dx.doi.org/10.3748/wjg.v20.i20.6006

Full Article (PDF)	WJG-20-6006.pdf
Full Article (Word)	WJG-20-6006.doc
Manuscript File	7193-Review.docx
Answering Reviewers	7193-Answering reviewers.pdf
Copyright License Agreement	7193-Copyright assignment.pdf
Peer-review Report	7193-Peer reviewer(s).pdf
Scientific Editor Work List	7193-Scientific editor work list.doc